Researcher receive 2014 Platinum Award for excellence during 2014 EAU Congress

NewsGuard 100/100 Score

Although Richard Sylvester officially retired in May 2012 after nearly 37 years at EORTC Headquarters, most of which were spent as the head of the Statistics Department, his scientific activities still keep him very busy.

Richard still works one day a week at EORTC Headquarters pursuing his main research interest, non-muscle invasive bladder cancer (NMIBC). The EORTC database of bladder cancer studies provides a valuable source of data for his research on prognostic factors and more specifically the prognostic and predictive effect of age.

Dr. Sylvester recently stepped down as the Statistical Editor of European Urology, and in recognition of his work for the journal, both as editor and reviewer and also for his publications in the journal, he recently received the journal's 2014 Platinum Award for excellence during the 2014 European Association of Urology (EAU) Congress in Stockholm.

Richard still maintains a number of activities with the EAU and is a member of both the EAU NMIBC Guidelines Panel and the EAU Guidelines Office Board. As part of his work for the EAU Guidelines Office, he chairs the Methodology Committee which is reviewing and updating the methodology used for guideline production.

As a joint project between the EORTC and the EAU, Richard has also launched a new systematic review and individual patient data meta-analysis to try to identify which NMIBC patients benefit from a single immediate instillation of chemotherapy after transurethral resection.

His spare time is devoted to his love of photography and his photographic activities both here in Brussels and with the Royal Photographic Society which is based in the United Kingdom. Photography provides a welcome artistic complement to the more scientific aspects which he will still pursue in his day to day life.

Source: European Organisation for Research and Treatment of Cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance